Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Oct 15, 2022; 14(10): 1949-1967
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1949
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1949
Figure 1 ELL-associated factor 2 protein is decreased in colorectal cancer tissue.
A: Representative immunohistochemical staining for ELL-associated factor 2 (EAF2) in colorectal adenocarcinoma tissue and adjacent tissue (magnification, 200 × and 400 ×); B: western blot showing lower EAF2 level in colorectal adenocarcinoma fresh tissue than in corresponding para-cancerous tissue (T, colorectal adenocarcinoma tissue; N, adjacent non-tumor tissue). EAF2: ELL-associated factor 2; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
- Citation: Feng ML, Wu C, Zhang HJ, Zhou H, Jiao TW, Liu MY, Sun MJ. Overexpression of ELL-associated factor 2 suppresses invasion, migration, and angiogenesis in colorectal cancer. World J Gastrointest Oncol 2022; 14(10): 1949-1967
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/1949.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.1949